Loading clinical trials...
Loading clinical trials...
A Phase III, Randomized, Observer-Blind, Placebo-Controlled, Multicenter Study to Assess Clinical Efficacy of a Cell-Derived Subunit Influenza Vaccine and an Egg-Derived Subunit Influenza Vaccine in the 2007-2008 Influenza Season in Healthy Adult Subjects
Conditions
Interventions
Cell culture-derived influenza vaccine
Egg-derived influenza virus vaccine
+1 more
Locations
56
United States
Site 14
Denver, Colorado, United States
Site 15
Pembroke Pines, Florida, United States
Site 17
South Miami, Florida, United States
Site 13
Lenexa, Kansas, United States
Site 2
Bardstown, Kentucky, United States
Site 1
St Louis, Missouri, United States
Start Date
October 1, 2007
Primary Completion Date
July 1, 2008
Completion Date
July 1, 2008
Last Updated
May 24, 2024
NCT01386424
NCT07169318
NCT07291635
NCT06599658
NCT06094010
NCT06753474
Lead Sponsor
Novartis Vaccines
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions